Browse > Article
http://dx.doi.org/10.3904/kjim.2010.25.3.337

High-Dose Fentanyl Patch for Cancer Pain of a Patient with Cholangiocarcinoma  

Kim, Jung-Han (Department of Internal Medicine, Hallym University Medical Center, Hallym University College of Medicine)
Kim, Mi (Department of Internal Medicine, Hallym University Medical Center, Hallym University College of Medicine)
Sung, Chong-Won (Department of Internal Medicine, Hallym University Medical Center, Hallym University College of Medicine)
Kim, Hyeoung-Su (Department of Internal Medicine, Hallym University Medical Center, Hallym University College of Medicine)
Jang, Hyun-Joo (Department of Internal Medicine, Hallym University Medical Center, Hallym University College of Medicine)
Shin, Young-Chul (Department of Internal Medicine, Hallym University Medical Center, Hallym University College of Medicine)
Jung, Joo-Young (Department of Internal Medicine, Hallym University Medical Center, Hallym University College of Medicine)
Publication Information
The Korean journal of internal medicine / v.25, no.3, 2010 , pp. 337-340 More about this Journal
Abstract
We describe here a patient who obtained a good analgesic effect with high-dose fentanyl patches for controlling cancer pain. A 52-year-old man was referred to our hospital because of severe cancer pain that was 7/10 on a numeric rating scale (NRS). He had been diagnosed with locally advanced cholangiocarcinoma 3 months previously. We prescribed weak opioids and an antidepressant, but his pain was not relieved. We introduced strong opioids (transdermal fentanyl patches for the background pain and a short-acting opioid for the breakthrough pain) and his pain was tolerable on 250 ${\mu}g$/hr of fentanyl patches for 3 months. With time, however, his pain intensity became worse and this reached up to 8/10 to 9/10 on the NRS. Percutaneous transhepatic biliary drainage was performed, which did not relieve his pain. We increased gradually the dose of transdermal fentanyl to 1,050 ${\mu}g$/hr (20 patches). At this dose, the patient was mentally alert, with good pain control (NRS 2/10 to 3/10) and no exacerbation of side effects. To the best of our knowledge, we report here on the highest dose of transdermal fentanyl that has been successfully used for treating a patient suffering from visceral cancer pain.
Keywords
Fentanyl; Neoplasms; Pain; Cholangiocarcinoma;
Citations & Related Records

Times Cited By SCOPUS : 0
연도 인용수 순위
  • Reference
1 Allan L, Hays H, Jensen NH, et al. Randomised crossover trial of transdermal fentanyl and sustained release oral morphine for treating chronic non-cancer pain. BMJ 2001;322:1154-1158.   DOI   ScienceOn
2 Ward SE, Goldberg N, Miller-McCauley V, et al. Patient-related barriers to management of cancer pain. Pain 1993;52:319-324.   DOI   ScienceOn
3 Bleeker CP, Bremer RC, Dongelmans DA, van Dongen RT, Crul BJ. Inefficacy of high-dose transdermal fentanyl in a patient with neuropathic pain: a case report. Eur J Pain 2001;5:325-329.   DOI   ScienceOn
4 Muijsers RB, Wagstaff AJ. Transdermal fentanyl: an updated review of its pharmacological properties and therapeutic efficacy in chronic cancer pain control. Drugs 2001;61:2289-2307.   DOI   ScienceOn
5 Grond S, Zech D, Lehmann KA, Radbruch L, Breitenbach H, Hertel D. Transdermal fentanyl in the long-term treatment of cancer pain: a prospective study of 50 patients with advanced cancer of the gastrointestinal tract or the head and neck region. Pain 1997;69:191-198.   DOI   ScienceOn
6 Zenz M, Willweber-Strumpf A. Opiophobia and cancer pain in Europe. Lancet 1993;341:1075-1076.   DOI   ScienceOn
7 Bercovitch M, Waller A, Adunsky A. High dose morphine use in the hospice setting: a database survey of patient characteristics and effect on life expectancy. Cancer 1999;86:871-877.   DOI   ScienceOn
8 Bercovitch M, Adunsky A. Patterns of high-dose morphine use in a home-care hospice service: should we be afraid of it? Cancer 2004;101:1473-1477.   DOI   ScienceOn
9 Mercadante S, Villari P, Ferrera P, Casuccio A. Addition of a second opioid may improve opioid response in cancer pain: preliminary data. Support Care Cancer 2004;12:762-766.   DOI   ScienceOn
10 Donner B, Zenz M, Strumpf M, Raber M. Long-term treatment of cancer pain with transdermal fentanyl. J Pain Symptom Manage 1998;15:168-175.   DOI   ScienceOn
11 Skaer TL. Management of pain in the cancer patient. Clin Ther 1993;15:638-649.